Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
Submitted by
admin
on February 6, 2012 - 9:47am
Source:
Yahoo/AP
News Tags:
FDA
Amgen
prostate cancer
Xgeva
Headline:
FDA questions benefit of Amgen's bone drug for new use in prostate cancer patients
Do Not Allow Advertisers to Use My Personal information
